Two Roads to One Pill
Ozempic is a pill now, but oral bioavailability wasn’t solved. How Novo Nordisk and Eli Lilly reached comparable results by two opposite routes.
Read moreTag: oral peptide delivery
The Third Battle, Better on Paper
A 2020 mouse study hit an oral bioavailability no approved oral peptide drug has matched in a human. Why lipid-based delivery — […]
Read moreThe Second Battle, Opened From the Inside
The Second Battle, Opened From the Inside Octreotide, acromegaly and the tight-junction trick that takes on the gut wall directly Rybelsus proved […]
Read more